Vitreoretinopathy, Proliferative

"Vitreoretinopathy, Proliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Descriptor ID	D018630
MeSH Number(s)	C11.768.890
Concept/Terms	Vitreoretinopathy, Proliferative Vitreoretinopathy, Proliferative Proliferative Vitreoretinopathies Vitreoretinopathies, Proliferative Vitreoretinopathy Neovascular Inflammatory Inflammatories, Vitreoretinopathy Neovascular Inflammatory, Vitreoretinopathy Neovascular Neovascular Inflammatories, Vitreoretinopathy Neovascular Inflammatory, Vitreoretinopathy Vitreoretinopathy Neovascular Inflammatories Proliferative Vitreoretinopathy

Below are MeSH descriptors whose meaning is more general than "Vitreoretinopathy, Proliferative".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Vitreoretinopathy, Proliferative [C11.768.890]

Below are MeSH descriptors whose meaning is related to "Vitreoretinopathy, Proliferative".

Below are MeSH descriptors whose meaning is more specific than "Vitreoretinopathy, Proliferative".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vitreoretinopathy, Proliferative" by people in this website by year, and whether "Vitreoretinopathy, Proliferative" was a major or minor topic of these publications.

Bar chart showing 28 publications over 17 distinct years, with a maximum of 3 publications in 2015 and 2019 and 2022 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2002	1	0	1
2005	1	0	1
2006	1	0	1
2007	1	0	1
2008	0	1	1
2014	1	0	1
2015	2	1	3
2016	0	1	1
2017	1	0	1
2018	2	0	2
2019	3	0	3
2020	1	1	2
2021	2	0	2
2022	3	0	3
2023	3	0	3
2024	1	0	1

Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.

Mammo DA, Wai K, Rahimy E, Pan CK, Srivastava SK, Mruthyunjaya P. Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy. Ophthalmology. 2024 08; 131(8):961-966.

View in: PubMed
Salabati M, Massenzio E, Kim J, Awh K, Anderson H, Mahmoudzadeh R, Wakabayashi T, Hsu J, Garg S, Ho AC, Khan MA. Primary Retinal Detachment Repair in Eyes Deemed High Risk for Proliferative Vitreoretinopathy: Surgical Outcomes in 389 Eyes. Ophthalmol Retina. 2023 11; 7(11):954-958.

View in: PubMed
Salabati M, Lee J, Patel SN, Hamburger J, Rama M, Gupta A, Mahmoudzadeh R, Xu D, Kuriyan AE, Khan MA. Risk factors for surgical failure after primary scleral buckling for rhegmatogenous retinal detachment. Can J Ophthalmol. 2024 04; 59(2):e155-e160.

View in: PubMed
Mundae R, Haq Z, Adams OE, Parke DW, Tang PH. Evolving Trends for the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments From Early to Late Phases of the COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2023 02; 54(2):78-83.

View in: PubMed
Starr MR, Huang D, Wong JC, Patel LG, Ammar M, Hsu J, Sivalingam A, Mehta S, Ho AC, Kuriyan AE, Khan MA, Cohen MN, Xu D, Lee D, Moster MR, Yonekawa Y. PREVALENCE, CHARACTERISTICS, AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN EYES WITH TRABECULECTOMY OR GLAUCOMA DRAINAGE DEVICES. Retina. 2022 11 01; 42(11):2039-2045.

View in: PubMed
Mahmoudzadeh R, Mokhashi N, Anderson H, Patel S, Salabati M, Chiang A, Kuriyan AE, Gupta OP, Mehta S, Garg SJ, Hsu J. Outcomes of Retinectomy without Lensectomy in Rhegmatogenous Retinal Detachments with Proliferative Vitreoretinopathy. Ophthalmol Retina. 2023 01; 7(1):52-58.

View in: PubMed
Israilevich RN, Starr MR, Mahmoudzadeh R, Salabati M, Swaminathan V, Huang D, Kuriyan AE, Yonekawa Y, Garg SJ, Mehta S, Regillo CD, Hsu J. Factors Associated With Good Visual Acuity Outcomes After Retinectomy in Eyes With Proliferative Vitreoretinopathy. Am J Ophthalmol. 2022 08; 240:143-148.

View in: PubMed
Cai LZ, Lin J, Starr MR, Obeid A, Ryan EH, Ryan C, Forbes NJ, Arias D, Ammar MJ, Patel LG, Capone A, Emerson GG, Joseph DP, Eliott D, Gupta OP, Regillo CD, Hsu J, Yonekawa Y. PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair. Br J Ophthalmol. 2023 04; 107(4):555-559.

View in: PubMed
Patel SN, Salabati M, Mahmoudzadeh R, Obeid A, Kuriyan AE, Yonekawa Y, Klufas MA, Garg SJ, Hsu J, Khan MA. SURGICAL FAILURES AFTER PRIMARY SCLERAL BUCKLING FOR RHEGMATOGENOUS RETINAL DETACHMENT: Comparison of Eyes With and Without Proliferative Vitreoretinopathy. Retina. 2021 Nov 01; 41(11):2288-2295.

View in: PubMed
Nagiel A, Yang U, Reid MW, Anulao KJ, Say EAT, Wong SC, Lee TC. VISUAL AND ANATOMIC OUTCOMES OF PEDIATRIC ENDOSCOPIC VITRECTOMY IN 326 CASES. Retina. 2020 Nov; 40(11):2083-2090.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement